Accordingly, CXCL9 strongly correlated with CD8+ T cell abundance in tumors, and high CXCL9 expression predicted better survival in ovarian and other cancer patients when compared to low CXCL9 expression (Figures 6E, 6F, and S8E). This evidence concerns the gene CXCL9 and cancer.